The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
复制标题
DOI:
--
复制
发表时间:
2007
影响因子:
3.1
通讯作者:
H. Higashitsuji;H. Higashitsuji;Yu Liu;T. Masuda;Takanori Fujita;H. Abdel-Aziz;S. Kongkham;S. Dawson
中科院分区:
文献类型:
--
作者:
H. Higashitsuji;H. Higashitsuji;Yu Liu;T. Masuda;Takanori Fujita;H. Abdel-Aziz;S. Kongkham;S. Dawson
Gankyrin is an oncoprotein commonly overexpressed in hepatocellular carcinomas. It interacts with multiple proteins and accelerates degradation of tumor suppressors Rb and p53. Since gankyrin consists of 7 ankyrin repeats and is structurally similar to IkappaBs, we investigated its interaction with NF-kappaB. We found that gankyrin directly binds to RelA. In HeLa and 293 cells, overexpression of gankyrin suppressed the basal as well as TNFalpha-induced transcriptional activity of NF-kappaB, whereas down-regulation of gankyrin increased it. Gankyrin did not affect the NF-kappaB DNA-binding activity or nuclear translocation of RelA induced by TNFalpha in these cells. Leptomycin B that inhibits nuclear export of RelA suppressed the NF-kappaB activity, which was further suppressed by gankyrin. The inhibitory effect of gankyrin was abrogated by nicotinamide as well as down-regulation of SIRT1, a class III histone deacetylase. Thus, gankyrin binds to NF-kappaB and suppresses its activity at the transcription level by modulating acetylation via SIRT1.